Higher-riskArticle link

Risperidone (Risperdal) for BPSD: Oral and Long-Acting Injection – Side Effects, Dosing & Administration

This article covers the specific side effects, dosing, and administration rules for risperidone (Risperdal) when used to manage behavioral and psychological symptoms of dementia (BPSD), including both oral forms and the long-acting injectable. We explain why low doses are critical, what to watch for in terms of movement disorders and other adverse effects, and how to safely start, monitor, and consider discontinuation. You'll find concrete steps for caregivers, including phrases to use with clinicians, and clear guidance on when to seek medical advice.

Key points

  • Risperidone for dementia BPSD should be used at low doses (0.25–2 mg/day) and only for severe, dangerous behaviors after non-drug approaches fail.
  • Elderly patients are more sensitive to side effects, especially extrapyramidal symptoms (stiffness, tremor, restlessness) and falls.
  • The oral form is preferred over long-acting injection because it allows flexible dosing and quick discontinuation if needed.
  • Monitor for orthostatic hypotension, sedation, and new movement problems daily; report any concerns to the prescriber immediately.
  • Combining risperidone with alcohol or other CNS depressants increases risks of severe drowsiness, falls, and death.
  • Many patients can be safely tapered off risperidone after 3–6 months; discuss a discontinuation plan with the clinician.

Why Risperidone Is Used in Dementia – and the Risks

Risperidone is an atypical antipsychotic sometimes prescribed to manage severe agitation, aggression, hallucinations, or delusions in people with dementia. Research shows that low doses (0.5 to 2 mg per day) can be effective for these behavioral symptoms, partly because it has minimal anticholinergic side effects compared to older drugs. However, the U.S. Food and Drug Administration has issued a black-box warning for all antipsychotics used in elderly patients with dementia, citing an increased risk of death from cerebrovascular events (like stroke) and infections. This risk is not theoretical: studies have found that even short-term use carries higher mortality. Because of this, risperidone should only be considered when behavioral symptoms cause significant distress to the person or danger to themselves or others, and after non-drug approaches have been tried.

How Dosing Differs for Dementia vs. Other Conditions

For dementia-related BPSD, dosing is much lower than for schizophrenia or bipolar disorder. Typical starting oral doses are 0.25 mg to 0.5 mg once or twice daily, with gradual increases to a maximum of 1.5 to 2 mg per day. Elderly patients are especially sensitive to risperidone, so 'start low and go slow' is the rule. The long-acting injection (Risperdal Consta) is rarely used in dementia because it cannot be quickly stopped if side effects occur; it is more common in chronic psychiatric conditions. For dementia, the oral form is preferred because it allows flexible dosing and immediate discontinuation if needed. Always discuss with the clinician whether the lowest effective dose is being used, and never adjust doses without medical guidance.

Common Side Effects to Watch For

The most concerning side effects in dementia patients include extrapyramidal symptoms (EPS) such as stiffness, tremors, shuffling walk, or restlessness (akathisia). These movement problems can be mistaken for worsening dementia or Parkinson's disease. Other common side effects include drowsiness, dizziness, increased risk of falls, constipation, and weight gain. Risperidone can also cause orthostatic hypotension (a drop in blood pressure when standing), leading to falls. Because it affects the central nervous system, combining it with alcohol or other sedating medications (like benzodiazepines or sleep aids) can worsen drowsiness and confusion. If you notice any new stiffness, unusual movements, or severe sedation, contact the prescriber immediately. The drug should be stopped if EPS appears.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. 1. Confirm the prescription is for the lowest possible starting dose: typically 0.25 mg to 0.5 mg once or twice daily for dementia. Ask the doctor: 'Is this the smallest dose we can try first?' Write down the exact dose and schedule.

  2. 2. Give the oral dose at bedtime to take advantage of its sedative effect, which can help with sundowning or nighttime agitation. Use a pill organizer to avoid missed or double doses.

  3. 3. For the first week, keep a daily log of behaviors (agitation, aggression, hallucinations) and side effects (drowsiness, stiffness, falls). Note the time of day and severity. Share this log with the clinician at follow-up.

  4. 4. Monitor for extrapyramidal symptoms (EPS) every day: watch for shuffling gait, rigid arms or legs, tremor, or the person saying they feel 'jittery' or can't sit still. If any appear, call the doctor immediately and follow their instructions. Do not stop the medication unless the doctor tells you to, as sudden stopping can cause withdrawal symptoms.

  5. 5. Check blood pressure and pulse before and after standing up for the first few days. If the person feels dizzy or faints, report it to the clinician. Encourage slow position changes (sit on edge of bed for a minute before standing).

  6. 6. Avoid giving risperidone with alcohol, over-the-counter sleep aids (like diphenhydramine/Benadryl), or other CNS depressants unless the doctor specifically approves. Check all medication labels for sedating ingredients.

  7. 7. If the person is on the long-acting injection (rare in dementia), know that effects last 2 weeks. You cannot stop it quickly. Discuss with the clinician a plan for monitoring side effects over the full injection cycle, and have a clear emergency contact if severe reactions occur.

  8. 8. Schedule a follow-up appointment within 2 to 4 weeks of starting to assess benefit and side effects. Ask: 'Is this still the right dose? Should we consider tapering if behaviors improve?'

  9. 9. If behaviors improve, discuss a plan for gradual dose reduction or discontinuation after 3 to 6 months. Research shows many patients can stop risperidone without relapse, especially if non-drug strategies are in place.

  10. 10. If no improvement after 4 weeks at a therapeutic dose (e.g., 1 mg/day), talk to the doctor about stopping the drug. It is not effective for everyone, and continuing without benefit only adds risk.

What not to do

  • Do not assume 'more is better' – higher doses increase side effects without more benefit. Stick to the lowest effective dose (0.5–2 mg/day for dementia). If the person seems more sedated or stiff, the dose may be too high.

  • Do not combine risperidone with other antipsychotics or strong sedatives without explicit doctor approval. This raises the risk of stroke, falls, and death. Always ask: 'Is it safe to give this with their other meds?'

  • Do not stop the medication abruptly without medical guidance, especially if it has been used for more than a few weeks. Sudden withdrawal can cause rebound agitation or anxiety. Taper slowly under a clinician's supervision.

  • Do not ignore new movement problems like stiffness, tremor, or restlessness. These are not 'just part of dementia' – they are likely drug-induced EPS and require immediate medical attention. Document and call the prescriber.

  • Do not use risperidone for mild agitation or sleep problems as a first choice. Non-drug approaches (e.g., calming routines, music, gentle touch) should be tried first. Antipsychotics carry serious risks and are reserved for severe, dangerous behaviors.

Practical tools

  • Side Effect & Behavior Log Template

    Create a simple daily chart with columns: Date, Time, Behavior (e.g., hitting, yelling), Severity (1-5), Medication Dose Given, Side Effects Noted (e.g., drowsy, stiff). Bring this to every doctor visit. Example phrase to say: 'I noticed that after the 0.5 mg dose at 8 PM, Mom was very stiff the next morning.'

  • Pill Organizer with Time Slots

    Use a weekly pill organizer with separate compartments for morning, noon, evening, and bedtime. This prevents double-dosing or missed doses. If the person is forgetful, you administer the dose yourself and mark it on a checklist.

  • Fall Prevention Setup

    Since risperidone can cause dizziness and orthostatic hypotension, place a sturdy chair near the bed so the person can sit before standing. Remove loose rugs, ensure good lighting, and use a nightlight. Teach the person to say 'I feel dizzy' and sit down immediately.

  • Communication Script for Doctor Visits

    Prepare a list of questions: 'What is the target symptom we are treating? How will we know if it's working? What side effects should I call you about right away? How long should we try this before deciding it's not helping? Is there a plan to reduce the dose later?'

  • Emergency Contact Card

    Keep a card in your wallet or phone with: patient name, medication name and dose, prescriber name and phone, and a note: 'If severe stiffness, confusion, or fall occurs, call 911 or go to ER.' Share this with other family members or facility staff.

  • Non-Drug Alternatives Checklist

    Before giving each dose, ask: 'Have we tried redirection, a calming activity, a walk, or a favorite music? Could this behavior be due to pain, hunger, or needing the bathroom?' Keep this checklist visible to remind yourself to try non-drug options first.

Discuss with your clinician

Ask: 'What is the specific target symptom we are treating with risperidone, and how will we measure success?'

Ask: 'What is the plan if my loved one develops stiffness, tremor, or falls? Should I stop the medication immediately?'

Ask: 'Given the black-box warning about increased risk of death, how do you weigh the benefits for my family member?'

Ask: 'Is there a plan to try a lower dose or discontinue after a few months? Can we schedule a deprescribing trial?'

Ask: 'Are there any drug interactions with their current medications (e.g., blood thinners, other sedatives, or anticholinergics)?'

Ask: 'If the long-acting injection is being considered, what is the plan if side effects occur before the next dose?'

Related guides

Sources